MAFG is a Transcriptional Repressor of Bile Acid Synthesis and Metabolism

Cell Metabolism

Volumn 21, Issue 2, 2015, Pages 298-311

  De Aguiar Vallim, Thomas Q ^a   Tarling, Elizabeth J ^a   Ahn, Hannah ^a   Hagey, Lee R ^b   Romanoski, Casey E ^c   Lee, Richard G ^d   Graham, Mark J ^d   Motohashi, Hozumi ^e   Yamamoto, Masayuki ^e   Edwards, Peter A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ISIS PHARMACEUTICALS   (United States)

^e TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CELL NUCLEUS RECEPTOR; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLIC ACID; CYTOCHROME P450 8B1; CYTOCHROME P450 ISOENZYME; MESSENGER RNA; PROTEIN FXR; SYNTHETIC DNA; TRANSCRIPTION FACTOR MAFG; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE ACID METABOLISM; BILE ACID SYNTHESIS; BINDING SITE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; FEEDBACK SYSTEM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION TERMINATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; GENETICS; HEP-G2 CELL LINE; MALE; METABOLISM; MUTANT MOUSE STRAIN; TUMOR CELL LINE;

MUS;

ANIMALS; BILE ACIDS AND SALTS; CELL LINE, TUMOR; HEP G2 CELLS; HUMANS; MAFG TRANSCRIPTION FACTOR; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS;

EID: 84922937097     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2015.01.007     Document Type: Article

References (46)

1. M. Ananthanarayanan, N. Balasubramanian, M. Makishima, D.J. Mangelsdorf, and F.J. Suchy Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor J. Biol. Chem. 276 2001 28857 28865
2. J.Y. Bass, J.A. Caravella, L. Chen, K.L. Creech, D.N. Deaton, K.P. Madauss, H.B. Marr, R.B. McFadyen, A.B. Miller, and W.Y. Mills Conformationally constrained farnesoid X receptor (FXR) agonists: heteroaryl replacements of the naphthalene Bioorg. Med. Chem. Lett. 21 2011 1206 1213
3. A. Båvner, S. Sanyal, J.A. Gustafsson, and E. Treuter Transcriptional corepression by SHP: molecular mechanisms and physiological consequences Trends Endocrinol. Metab. 16 2005 478 488
4. W.T. Beher, G.D. Baker, W.L. Anthony, and M.E. Beher The feedback control of cholestrol biosynthesis Henry Ford Hosp. Med. Bull. 9 1961 201 213
5. B.J. Bennett, T.Q. de Aguiar Vallim, Z. Wang, D.M. Shih, Y. Meng, J. Gregory, H. Allayee, R. Lee, M. Graham, and R. Crooke Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation Cell Metab. 17 2013 49 60
6. H.K. Chong, A.M. Infante, Y.K. Seo, T.I. Jeon, Y. Zhang, P.A. Edwards, X. Xie, and T.F. Osborne Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1 Nucleic Acids Res. 38 2010 6007 6017
7. H.K. Chong, J. Biesinger, Y.K. Seo, X. Xie, and T.F. Osborne Genome-wide analysis of hepatic LRH-1 reveals a promoter binding preference and suggests a role in regulating genes of lipid metabolism in concert with FXR BMC Genomics 13 2012 51
8. T.Q. de Aguiar Vallim, E.J. Tarling, and P.A. Edwards Pleiotropic roles of bile acids in metabolism Cell Metab. 17 2013 657 669
9. T.Q. de Aguiar Vallim, E.J. Tarling, T. Kim, M. Civelek, Á. Baldán, C. Esau, and P.A. Edwards MicroRNA-144 regulates hepatic ATP binding cassette transporter A1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid X receptor Circ. Res. 112 2013 1602 1612
10. D. Duran-Sandoval, B. Cariou, F. Percevault, N. Hennuyer, A. Grefhorst, T.H. van Dijk, F.J. Gonzalez, J.C. Fruchart, F. Kuipers, and B. Staels The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition J. Biol. Chem. 280 2005 29971 29979
11. R.M. Evans, and D.J. Mangelsdorf Nuclear Receptors, RXR, and the Big Bang Cell 157 2014 255 266
12. B. Goodwin, S.A. Jones, R.R. Price, M.A. Watson, D.D. McKee, L.B. Moore, C. Galardi, J.G. Wilson, M.C. Lewis, and M.E. Roth A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis Mol. Cell 6 2000 517 526
13. Y. Hirotsu, F. Katsuoka, R. Funayama, T. Nagashima, Y. Nishida, K. Nakayama, J.D. Engel, and M. Yamamoto Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks Nucleic Acids Res. 40 2012 10228 10239
14. A.F. Hofmann, and L.R. Hagey Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics Cell. Mol. Life Sci. 65 2008 2461 2483
15. W. Huang, B.T. Sherman, and R.A. Lempicki Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat. Protoc. 4 2009 44 57
16. T. Inagaki, M. Choi, A. Moschetta, L. Peng, C.L. Cummins, J.G. McDonald, G. Luo, S.A. Jones, B. Goodwin, and J.A. Richardson Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis Cell Metab. 2 2005 217 225
17. T. Inagaki, A. Moschetta, Y.K. Lee, L. Peng, G. Zhao, M. Downes, R.T. Yu, J.M. Shelton, J.A. Richardson, and J.J. Repa Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor Proc. Natl. Acad. Sci. USA 103 2006 3920 3925
18. M.B. Kannan, V. Solovieva, and V. Blank The small MAF transcription factors MAFF, MAFG and MAFK: current knowledge and perspectives Biochim. Biophys. Acta 1823 2012 1841 1846
19. F. Katsuoka, H. Motohashi, J.D. Engel, and M. Yamamoto Nrf2 transcriptionally activates the mafG gene through an antioxidant response element J. Biol. Chem. 280 2005 4483 4490
20. F. Katsuoka, H. Motohashi, T. Ishii, H. Aburatani, J.D. Engel, and M. Yamamoto Genetic evidence that small maf proteins are essential for the activation of antioxidant response element-dependent genes Mol. Cell. Biol. 25 2005 8044 8051
21. T.A. Kerr, S. Saeki, M. Schneider, K. Schaefer, S. Berdy, T. Redder, B. Shan, D.W. Russell, and M. Schwarz Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis Dev. Cell 2 2002 713 720
22. I. Kim, S.H. Ahn, T. Inagaki, M. Choi, S. Ito, G.L. Guo, S.A. Kliewer, and F.J. Gonzalez Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine J. Lipid Res. 48 2007 2664 2672
23. S. Kir, Y. Zhang, R.D. Gerard, S.A. Kliewer, and D.J. Mangelsdorf Nuclear receptors HNF4α and LRH-1 cooperate in regulating Cyp7a1 in vivo J. Biol. Chem. 287 2012 41334 41341
24. B. Kong, L. Wang, J.Y. Chiang, Y. Zhang, C.D. Klaassen, and G.L. Guo Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice Hepatology 56 2012 1034 1043
25. F. Kuipers, V.W. Bloks, and A.K. Groen Beyond intestinal soap - bile acids in metabolic control Nat. Rev. Endocrinol. 10 2014 488 498
26. H. Kurokawa, H. Motohashi, S. Sueno, M. Kimura, H. Takagawa, Y. Kanno, M. Yamamoto, and T. Tanaka Structural basis of alternative DNA recognition by Maf transcription factors Mol. Cell. Biol. 29 2009 6232 6244
27. Y.K. Lee, D.R. Schmidt, C.L. Cummins, M. Choi, L. Peng, Y. Zhang, B. Goodwin, R.E. Hammer, D.J. Mangelsdorf, and S.A. Kliewer Liver receptor homolog-1 regulates bile acid homeostasis but is not essential for feedback regulation of bile acid synthesis Mol. Endocrinol. 22 2008 1345 1356
28. F.Y. Lee, T.Q. de Aguiar Vallim, H.K. Chong, Y. Zhang, Y. Liu, S.A. Jones, T.F. Osborne, and P.A. Edwards Activation of the farnesoid X receptor provides protection against acetaminophen-induced hepatic toxicity Mol. Endocrinol. 24 2010 1626 1636
29. F. Li, C. Jiang, K.W. Krausz, Y. Li, I. Albert, H. Hao, K.M. Fabre, J.B. Mitchell, A.D. Patterson, and F.J. Gonzalez Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity Nat. Commun. 4 2013 2384
30. J. Li-Hawkins, M. Gåfvels, M. Olin, E.G. Lund, U. Andersson, G. Schuster, I. Björkhem, D.W. Russell, and G. Eggertsen Cholic acid mediates negative feedback regulation of bile acid synthesis in mice J. Clin. Invest. 110 2002 1191 1200
31. T.T. Lu, M. Makishima, J.J. Repa, K. Schoonjans, T.A. Kerr, J. Auwerx, and D.J. Mangelsdorf Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors Mol. Cell 6 2000 507 515
32. M. Makishima, A.Y. Okamoto, J.J. Repa, H. Tu, R.M. Learned, A. Luk, M.V. Hull, K.D. Lustig, D.J. Mangelsdorf, and B. Shan Identification of a nuclear receptor for bile acids Science 284 1999 1362 1365
33. P.R. Maloney, D.J. Parks, C.D. Haffner, A.M. Fivush, G. Chandra, K.D. Plunket, K.L. Creech, L.B. Moore, J.G. Wilson, and M.C. Lewis Identification of a chemical tool for the orphan nuclear receptor FXR J. Med. Chem. 43 2000 2971 2974
34. C. Mataki, B.C. Magnier, S.M. Houten, J.S. Annicotte, C. Argmann, C. Thomas, H. Overmars, W. Kulik, D. Metzger, J. Auwerx, and K. Schoonjans Compromised intestinal lipid absorption in mice with a liver-specific deficiency of liver receptor homolog 1 Mol. Cell. Biol. 27 2007 8330 8339
35. J.S. Menet, J. Rodriguez, K.C. Abruzzi, and M. Rosbash Nascent-Seq reveals novel features of mouse circadian transcriptional regulation eLife 1 2012 e00011
36. H. Motohashi, T. O'Connor, F. Katsuoka, J.D. Engel, and M. Yamamoto Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors Gene 294 2002 1 12
37. D.J. Parks, S.G. Blanchard, R.K. Bledsoe, G. Chandra, T.G. Consler, S.A. Kliewer, J.B. Stimmel, T.M. Willson, A.M. Zavacki, D.D. Moore, and J.M. Lehmann Bile acids: natural ligands for an orphan nuclear receptor Science 284 1999 1365 1368
38. M.J. Potthoff, S.A. Kliewer, and D.J. Mangelsdorf Endocrine fibroblast growth factors 15/19 and 21: from feast to famine Genes Dev. 26 2012 312 324
39. V.K. Ridaura, J.J. Faith, F.E. Rey, J. Cheng, A.E. Duncan, A.L. Kau, N.W. Griffin, V. Lombard, B. Henrissat, and J.R. Bain Gut microbiota from twins discordant for obesity modulate metabolism in mice Science 341 2013 1241214
40. D.W. Russell The enzymes, regulation, and genetics of bile acid synthesis Annu. Rev. Biochem. 72 2003 137 174
41. K.K. Ryan, V. Tremaroli, C. Clemmensen, P. Kovatcheva-Datchary, A. Myronovych, R. Karns, H.E. Wilson-Pérez, D.A. Sandoval, R. Kohli, F. Bäckhed, and R.J. Seeley FXR is a molecular target for the effects of vertical sleeve gastrectomy Nature 509 2014 183 188
42. J.A. Shavit, H. Motohashi, K. Onodera, J. Akasaka, M. Yamamoto, and J.D. Engel Impaired megakaryopoiesis and behavioral defects in mafG-null mutant mice Genes Dev. 12 1998 2164 2174
43. C.J. Sinal, M. Tohkin, M. Miyata, J.M. Ward, G. Lambert, and F.J. Gonzalez Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis Cell 102 2000 731 744
44. A.M. Thomas, S.N. Hart, B. Kong, J. Fang, X.B. Zhong, and G.L. Guo Genome-wide tissue-specific farnesoid X receptor binding in mouse liver and intestine Hepatology 51 2010 1410 1419
45. L. Wang, Y.K. Lee, D. Bundman, Y. Han, S. Thevananther, C.S. Kim, S.S. Chua, P. Wei, R.A. Heyman, M. Karin, and D.D. Moore Redundant pathways for negative feedback regulation of bile acid production Dev. Cell 2 2002 721 731
46. Y. Zhang, F.Y. Lee, G. Barrera, H. Lee, C. Vales, F.J. Gonzalez, T.M. Willson, and P.A. Edwards Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice Proc. Natl. Acad. Sci. USA 103 2006 1006 1011